Using immunohistochemistry (IHC) for cleaved caspase 3 (CC3, a known apoptosis marker) we confirmed that the core of the tumors had the highest levels of apoptosis, with increased apoptosis observed throughout the tumor, Fig 3 G. The gene discussed is CASP3; the disease is neoplasm.